Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity
Titel:
Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity
Auteur:
Hafner, Marc Mills, Caitlin E. Subramanian, Kartik Chen, Chen Chung, Mirra Boswell, Sarah A. Everley, Robert A. Liu, Changchang Walmsley, Charlotte S. Juric, Dejan Sorger, Peter K.